SCHEDULE 13G/A

Vistagen Therapeutics Inc

Common Stock, par value $0.001 per share · CUSIP: 92840H400

Event date: 2025-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• StemPoint Capital LP

  Shares: 616,749.00 · Class: 1.5%

• StemPoint Capital Management GP LLC

  Shares: 616,749.00 · Class: 1.5%

• Michelle Ross

  Shares: 616,749.00 · Class: 1.5%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.